Navigation Links
Telik Announces Publication of a Case Report of a Sustained Hematologic Response in Myelodysplastic Syndrome Following an Abbreviated Exposure to Oral Telintra(R) (Ezatiostat HCl)
Date:6/21/2010

PALO ALTO, Calif., June 21 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) today announced the publication of a case report by Quddus et al., Oral Ezatiostat HCl (Telintra) and Myelodysplastic Syndrome: A case report of sustained hematologic response following an abbreviated exposure. Journal of Hematology & Oncology 2010, 3:16.  This case report describes a patient who experienced a sustained hematologic response in all three blood cell lines continuing for over a year, after an abbreviated course of oral Telintra received while on the current Phase 2 Study in Low to Intermediate-1 Risk Myelodysplastic Syndrome.  A copy of this case report can be found online at http://www.jhoonline.org/content/pdf/1756-8722-3-16.pdf.

Background on MDS and Telintra

The myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis (blood cell production) involving one or more cell lineages (red blood cells, white blood cells or platelets) and a variable risk of transformation to acute myeloid leukemia (AML).  MDS becomes more common with age.  It is estimated that MDS affects approximately 300,000 people worldwide.  According to the American Cancer Society, 10,000–20,000 new cases of MDS are diagnosed each year in the United States, with survival rates ranging from six months to six years.  MDS patients often require blo
'/>"/>

SOURCE Telik, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
2. Telik Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2
3. Telik Announces Telintra Presentation at American Society of Hematology Annual Meeting
4. Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies
5. Teliks Proteasome Inhibitor Program Meets a Preclinical Development Milestone
6. Telik Announces Presentation at ASCO Annual Meeting
7. Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
8. Telik Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
9. Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Combination With Lenalidomide (Revlimid(R)) in Patients With Myelodysplastic Syndrome (MDS)
10. Telik Announces Third Quarter 2009 Financial Results
11. Telik Announces Fourth Quarter and 2009 Year End Financial Results and 2010 Financial Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 2014 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ... to report its second quarter 2014 financial results on ... Dr. J. Joseph Kim and CFO ... a corporate update, and participate in a live Q&A ... for VGX-3100, Inovio,s immune therapy targeting pre-cancers and cancers ...
(Date:7/31/2014)... , Indien, August 1, 2014 ... BioQuiddity Inc. gaben heute bekannt, vor kurzem ... Anästhesieanwendungen zur Schmerzbehandlung nach chirurgischen Eingriffen eine ... Gebiet der Europäischen Union und weiterer europäischer ... versehene und mit Ropivacain gefüllte OneDose ReadyfusOR ...
(Date:7/31/2014)... Calif., July 31, 2014 IRIDEX Corporation (Nasdaq: ... quarter and six months ended June 28, 2014.  ... 2014, up 15% from $9.2 million in the 2013 second ... quarter of 2014. Revenues for the first six months of ... the first six months of last year. , Gross ...
Breaking Medicine Technology:Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 2Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 3Cipla und BioQuiddity geben EU-Geschäftspartnerschaft für OneDose-ReadyfusOR zur Schmerzbehandlung nach chirurgischen Eingriffen bekannt 2Cipla und BioQuiddity geben EU-Geschäftspartnerschaft für OneDose-ReadyfusOR zur Schmerzbehandlung nach chirurgischen Eingriffen bekannt 3IRIDEX Reports 2014 Second Quarter, Six-Month Results 2IRIDEX Reports 2014 Second Quarter, Six-Month Results 3IRIDEX Reports 2014 Second Quarter, Six-Month Results 4IRIDEX Reports 2014 Second Quarter, Six-Month Results 5IRIDEX Reports 2014 Second Quarter, Six-Month Results 6IRIDEX Reports 2014 Second Quarter, Six-Month Results 7
... Nov. 14, 2011 Dynex Technologies, Inc., a ... testing easier, more cost-effective, and less labor intensive, ... sample processing system at the MEDICA 2011 – ... November 16 to 19, 2011. The Agility system ...
... Cheyenne Regional Medical Center is expanding its emergency ... AirLife Denver medical helicopter service in Cheyenne. ... and HCA-HealthONE, which operates AIRLIFE Denver. (Photo: ... and sonic green helicopter will be stationed in Cheyenne ...
Cached Medicine Technology:Dynex Technologies to Showcase Agility™ ELISA Processor at MEDICA 2011 - Hall 3, Stand D45-6 2Cheyenne Regional Medical Center Announces New Air Ambulance Service Partnership with HealthONE's AirLife Denver 2Cheyenne Regional Medical Center Announces New Air Ambulance Service Partnership with HealthONE's AirLife Denver 3
(Date:8/1/2014)... (PRWEB) August 01, 2014 Transparency ... announced the addition of a comprehensive report on ... ‘Infusion System Market (Large Volume, Disposable, Syringe, Ambulatory ... Growth, Trends And Forecast, 2013 – 2019’ is ... http://www.transparencymarketresearch.com . , To begin with, the ...
(Date:8/1/2014)... HealthDay Reporter THURSDAY, July 31, ... risk of heart attack and stroke, particularly if you work ... health officials reported Thursday. But being unemployed might be ... risk include job stress, exposure to air pollution -- like ... Dr. Sara Luckhaupt, from the National Institute for Occupational Safety ...
(Date:8/1/2014)... OR (PRWEB) August 01, 2014 In ... called hydrotherapy – was fundamental to the practice of ... water researcher Sharon Kleyne, water therapy has been relegated ... time when climate change, water shortages, drought and pollution ... diseases, the Sharon Kleyne Hour Power of Water host ...
(Date:8/1/2014)... August 01, 2014 According to the Suspension ... a bodybuilding program for men and women who want to ... of 191 suspension exercises and 27 intense workouts that help ... in its review that the Suspension Revolution 2.0 program provides ... how to create diet plans that help keep ...
(Date:8/1/2014)... Blindness is a reversible ailment these days . ... despite well-meaning efforts, still have a long way to go ... blindness that does not involve any kind of health risk ... takes the “slack” from the mainstream by providing a cure ... , Alternative health specialist Kevin Richardson actually has the ...
Breaking Medicine News(10 mins):Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 2Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 3Health News:Some Jobs Harder on the Heart Than Others, Report Finds 2Health News:Water Researcher Advocates Reevaluation of 18th and 19th Century Water Therapy Movement 2Health News:Water Researcher Advocates Reevaluation of 18th and 19th Century Water Therapy Movement 3Health News:Suspension Revolution 2.0 PDF Review Exposes Dan Long's Program For Building Muscle – Vkool.com 2Health News:Suspension Revolution 2.0 PDF Review Exposes Dan Long's Program For Building Muscle – Vkool.com 3Health News:The Miracle Cure Review | The Unbeatable Secret to Reversing Any Vision Problem – Vinamy.com 2
... been found by researchers to be more effective than ... borderline personality disorder. This study , which included 38 ... ages of 19 and 51 was conducted by researchers ... differences in rapid mood shift, impulsivity and aggression when ...
... that HRT could reduce risk of heart attack in post ... 1000 women of ages 50 to 69 conducted by the ... study was to determine whether a combination// of oestrogen and ... menopausal women who had already sufferd a previous attack. ...
... observe why surgery may trigger cognitive problems in some ... some older people develop problems with memory and other mental ... Operative Cognitive Dysfunction (POCD).Often relatives will say that the person ... It was assumed, at first, that the anaesthetic was to ...
... skills do home care which is advantageous for ... or chronic obstructive pulmonary disease (COPD) - can be ... A new study from researchers at Barcelona// Hospital, Spain, ... care in the home setting cuts costs, re-admission to ...
... researchers suggests that nurses and junior doctors can both carry ... competence.,There's a shortage of junior doctors in the UK// and ... to take over some of their roles. Researchers in Ireland, ... nurses assess people before surgery. ,They found that ...
... a recent survey, it has been observed that there are ... fasciitis is an inflammation of the band of fibrous tissue ... and the heel.// It causes excruciating pain first thing in ... eases off once you have been on the move for ...
Cached Medicine News:
PTC-100 cycler with gold/silver block with Hot Bonnet heated lid, holds one 96-well V-plate or96x0.2ml tubes...
... up kit. Includes configured Laptop PC with ... 1 MultiBlock satellite thermal Cycler (non-robotic). ... friendly software. Store/track run data. ... Outstanding uniformity. Advanced control algorithms ...
PxE thermal Cycler. 0.5ml block holds 48 0.5 ml tubes or 96 0.3 ml tubes. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced reaction times. User frien...
PxE thermal Cycler. 0.2ml, 96 well block holds 96 tubes or 1 x 96 well plate. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced reaction times. User f...
Medicine Products: